Best GLP-1 on TRICARE Formulary: Zepbound vs. Wegovy (2026)

Zepbound leads Wegovy on weight loss in the direct comparison: 20.2% versus 13.7% at 72 weeks in adults with obesity without diabetes. But the best GLP-1 on TRICARE formulary for you also depends on your covered product and medical needs. Wegovy deserves a separate look for teens or established cardiovascular disease. Neither drug has a guaranteed $44 copay.¹²

Affiliate disclosure: The RX Index may earn a commission from treatment-path links on this site. Commercial links on this page are labeled. Payment does not change the coverage facts. The RX Index is independent of TRICARE, the Department of Defense, and Express Scripts.

Sources: the SURMOUNT-5 trial, TRICARE's medication FAQ, and its current pharmacy-cost schedule.¹³⁴

Here's a difference worth checking before your visit: Zepbound has a separate sleep-apnea use. DoD's published sleep-apnea criteria do not include the generic weight-loss pill trial listed in its adult weight-management criteria. That's a different medical reason for treatment—not a shortcut based on snoring.⁵⁶

This page is for you if: you have TRICARE Prime, Select, Reserve Select, Retired Reserve, Young Adult, US Family Health Plan, or CHCBP, and you want to know which drug and coverage questions to bring to your appointment.³

Not for you if: you want to use TRICARE For Life, direct-care-only status, or NATO/Partnership-for-Peace status for weight-loss medication. Jump to What if TRICARE won't cover you. For type 2 diabetes, start with Does TRICARE cover Mounjaro?. This page compares FDA-approved medicines, not compounded substitutes.⁷

One more thing: this is a comparison, not a prescription. Your clinician decides what's safe for you. A medication's FDA approval, its TRICARE coverage, and your final pharmacy bill are three separate checks.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

What this verification covers: public coverage rules, the published copay schedule, drug labels, trials, and the listed cash-pay terms. It is not a live check of your personal benefit or every product's formulary tier. The policy discussion uses DoD's published February 2025 criteria, not a verified September 2026 form. Your provider should use the current form linked to your medication in the official formulary tool.

Which GLP-1s does TRICARE cover for weight loss?

TRICARE's own FAQ names three weight-management GLP-1s for eligible plans: Wegovy, Zepbound, and Saxenda, each requiring prior authorization. It also calls for a medical-necessity form for Saxenda. That is not proof that every new strength, tablet, or device has the same coverage or copay.³

Here's the comparison—and what each row can actually tell you.

Sources: TRICARE's coverage FAQ and the current prescribing information for Zepbound, Wegovy, Saxenda, and Foundayo.³⁸²⁹¹⁰

Do not substitute a generic diabetes product for Saxenda in this table. A shared ingredient name does not establish the same approved weight-management product, dose, or benefit.

The right GLP-1 provider isn't the same for everyone—it depends on your state, your insurance and formulary, your medication needs, your preferred treatment format, and your budget. Use The RX Index's Find My GLP-1 Path tool to explore treatment paths before you choose. For a TRICARE-covered prescription, confirm the provider and medication with your benefit administrator before paying.

Not sure which row is you? Start with six questions you can take to your provider. No account, no signup, and no promise of approval.

Build my TRICARE appointment checklist →

Which is the best GLP-1 on TRICARE formulary for your situation?

Zepbound has the stronger weight-loss result in the direct comparison with Wegovy up to 2.4 mg. Wegovy has different age and medical-use options. That makes the trial a useful starting point—not a reason to ignore a covered alternative, a side effect, or a health condition.¹²

The head-to-head trial

Most “Zepbound vs. Wegovy” numbers online come from different trials with different people. That's apples to oranges. SURMOUNT-5 put both drugs in the same trial for 72 weeks.

The trial included 751 adults with obesity without diabetes. Participants received the highest doses they could tolerate within the study: tirzepatide 10 or 15 mg, or semaglutide 1.7 or 2.4 mg. Not everyone took the highest possible dose.¹

For a 250-pound person, that gap is roughly 16 pounds: 250 × (20.2% − 13.7%) = 16.25 pounds. That's an illustration of the trial averages, not a forecast of what you will lose.

Digestive side effects were common in both groups. The study was funded by Lilly, Zepbound's manufacturer.¹

What about the other trial numbers?

Different study lengths and methods can change the headline number. Keep the trial attached to the claim.

Sources: STEP 1/Wegovy prescribing information, the published STEP UP trial and Novo Nordisk's results announcement, OASIS 4, SCALE, and Lilly's ATTAIN-1 report. The 18.5-pound figure converts 8.4 kg using 2.20462 pounds per kilogram.^21112131415

The separate path: sleep apnea

Zepbound has an FDA-approved use for moderate-to-severe obstructive sleep apnea in adults with obesity, approved in December 2024. Wegovy does not have that sleep-apnea indication.⁵²

The verified DoD policy document describes a separate Zepbound sleep-apnea path. It includes a sleep study within the previous five years and documented lifestyle treatment. It does not include the generic weight-loss pill trial listed for adult weight management.⁶

Bring the actual sleep-study report. Your provider needs the apnea-hypopnea index, or AHI—the number of breathing interruptions per hour—and your BMI. The current form must settle the exact cutoffs and any other requirements.

Plain English: a diagnosed sleep problem can change which coverage request your clinician considers. Snoring alone cannot. This is not a promised faster approval, and it does not automatically override a benefit exclusion.

Ask for the exact product—not just the brand

Zepbound comes in different presentations. The existence of a pen, vial, or KwikPen does not prove that your benefit treats them the same.⁸

Ask your provider and pharmacy to agree on the drug, strength, device, and days supplied before the prescription is sent. When needed, the pharmacy can identify the product's National Drug Code, or NDC.

The useful question is: “Is this exact product covered for my use?” Not: “Does TRICARE cover tirzepatide?”

When Wegovy deserves a separate look

• Your child is 12 to 17. Wegovy injection has an FDA-approved weight-management use for this age group with obesity. Saxenda is another FDA-approved option for eligible adolescents who weigh more than 60 kg, about 132 pounds. The FDA labels do not, by themselves, establish TRICARE approval.²⁹
• You have established cardiovascular disease and overweight or obesity. Wegovy has an FDA-approved use to reduce major cardiovascular events in this group. Tell your clinician about a prior heart attack, stroke, or peripheral artery disease.²
• Tirzepatide didn't agree with you. Different molecule, different side-effect experience for some people. Talk to your clinician.⁸²
• You will not inject. Wegovy tablets are an FDA-approved adult option. Check tablet coverage separately; a covered injection does not establish a covered pill.²

If that's you, our Does TRICARE cover Wegovy? page goes deeper. For Zepbound-specific questions, see Does TRICARE cover Zepbound?.

Does TRICARE cover the Wegovy pill or Foundayo?

The Wegovy pill and Foundayo are FDA-approved. Their exact current TRICARE coverage and tier still need a product-level check. Check each product in the official formulary tool. A drug being absent from a short FAQ—or present on another plan's form—is not enough to settle your benefit.²¹⁰¹⁶

Wegovy tablets were FDA-approved in December 2025. Foundayo was approved on April 1, 2026. Both are real prescription medicines, not compounded oral substitutes.¹⁷¹⁸

Drug instructions come from the prescribing information. Prices were checked September 22, 2026; the complete dose and offer table is below.^2101920

One useful rule: a formulary meeting is not a pharmacy approval. Don't pay cash or switch treatment because a review is scheduled. Look for the actual product result and the rules that apply to you.¹⁶

What does each one cost with TRICARE in 2026?

For most beneficiaries, a covered brand-formulary drug has a standard copay of $44 through home delivery or $48 at network retail. A covered non-formulary drug is generally $85 in either channel. These are published benefit rates, not verified price quotes for each GLP-1.²¹

The standard 2026–2027 schedule

TRICARE also has a non-covered category. Don't confuse “non-formulary” with “not covered at all.” A non-formulary drug can have a coverage or medical-necessity process; a benefit exclusion is a different problem.⁴²²

Who pays different rates?

Source: TRICARE's current pharmacy-cost schedule and its USFHP guidance.⁴²³

Why you'll see different copays online. Older articles still show earlier rates. TRICARE's own cost page also displays an older table alongside the 2026–2027 amounts. We cross-checked the current figures against TRICARE's separate 2026 copay announcement. A different quote can also reflect your beneficiary category or fill details—not necessarily a pharmacy error.⁴²¹

Which tier is your drug in?

This is the check that can move a standard home-delivery copay from $44 to $85.

Prior authorization does not tell you the tier. And the absence of a medical-necessity warning in a short FAQ does not prove that a drug is brand-formulary.²²¹⁶

Open the TRICARE Formulary Search Tool. Enter the medication and requested details, then choose the correct strength and form. Record the coverage restrictions, required forms, fill options, and cost shown. Screenshot the result. Bring it to your visit.¹⁶

Home delivery vs. retail: the same drug over the same 90 days

At the standard brand-formulary rate, one eligible 90-day home-delivery fill is $44. Three 30-day retail fills are $144. That's a $100 difference for the same 90 days: $48 × 3 − $44.⁴

That comparison works only when the same prescription can be filled for those quantities. A quantity limit, dose change, or 28-day package can change the calculation. Check the actual days supplied before treating a “monthly” price as a calendar-month budget.¹⁶⁸

Can you fill it at the base pharmacy?

Yes, if you're eligible, your medication is approved, and the military pharmacy offers it. Express Scripts lists participating military pharmacies alongside home delivery and network retail as fill options. Call first. Stocking varies by facility.²⁴

The $25 savings card is not yours

The commercial copay offers from Novo Nordisk and Lilly exclude people enrolled in government programs such as TRICARE. Don't budget around the commercial-insurance ad. Their separate self-pay offers use different terms and can allow eligible government-insured patients to pay outside insurance.²⁵²⁶

Two branches that change the process

US Family Health Plan: USFHP runs its own pharmacy program, not the standard TRICARE Pharmacy Program. Your designated plan handles its forms and fills.²³

Overseas: the process can depend on where you fill the prescription. Overseas retail purchases can require payment up front and a reimbursement claim; follow the applicable overseas and International SOS instructions rather than assuming the U.S. retail table applies unchanged.²⁷

What does TRICARE require before it approves Zepbound or Wegovy?

Your provider needs the current form for the exact drug and medical use. DoD's published adult weight-management criteria include BMI requirements, six months of lifestyle treatment, and a three-month generic weight-loss pill trial or a qualifying reason not to take one. Use those facts to gather records—not as a substitute for the current form.⁶

A prior authorization, or PA, is the plan's approval before it pays. A medical-necessity request is a separate review explaining why a particular drug is needed.²²

The table below turns the published requirements into appointment questions. Use it to gather your records while the office checks the current form.

Coverage-criteria source: DoD's February 2025 P&T minutes and Appendix D. Safety sources: current Wegovy and Zepbound prescribing information.⁶²⁸

What counts as the generic-pill trial?

The published DoD criteria name phentermine, benzphetamine, diethylpropion, and phendimetrazine. They describe an inadequate response as less than 5% weight loss after the trial, with separate provisions for a reason the drug cannot be used.⁶

High blood pressure alone is not the whole record. The published DoD criteria specifically describe blood pressure that remains above goal despite more than two medicines. Have your clinician check the current exception rules and document the readings, medicines, and medical reason a proposed drug would be unsafe. Do not change medicines just to satisfy a checklist.⁶

“I lost weight but stalled” needs the current form checked. Bring the starting and ending weights and dates. Ask your clinician to check the current rules for your documented response. A question number from an article is not an approval.

The honest timeline

There is no universal six-month wait from the day you ask. Your existing records matter. The office may already have the history needed to submit a request, or it may need more documentation.

For the review itself, TRICARE says the standard prior-authorization process can take about 10 days after the request is received. That's a general estimate, not a guaranteed GLP-1 turnaround. Ask your provider's office how it confirms receipt and tracks missing information.²³

Paying cash does not guarantee that TRICARE will cover the same medication later. Before starting, ask the TRICARE clinician how prior treatment would be assessed on a future request.

Active duty

Start with your military clinician and pharmacy team. A $0 covered-drug copay does not remove clinical or authorization requirements. Ask them how to handle a denial or reconsideration under your current benefit.⁴³

For more detail, see TRICARE Wegovy prior authorization. For the note you can take to your appointment, use the checklist below.

What should I take to my TRICARE appointment?

Take a short record of your benefit, the drug being considered, and the facts the office needs to check. You do not need to arrive knowing how to fill out an insurance form. Use these six prompts to keep the visit focused.

Your six-question TRICARE appointment checklist

Copy or print this table. Fill in what you know; leave the rest as questions for the office.

Message to copy for your provider:

“Before we choose a program or send a prescription, can we check my benefit and the exact product? Please tell me which current approval form applies, which records are missing, and who will submit it. I'd also like to know the pharmacy cost and days supplied before I pay.”

This is a planning sheet, not an eligibility result. No personal details need to be entered on this website.

Should you use Ro while sorting out TRICARE coverage?

Ro's published option for TRICARE members is cash-pay—not a way to use your TRICARE copay. Ro says members may be eligible for certain cash-pay treatments after clinical review. That can be useful when you deliberately choose self-pay, but it adds a membership fee to the medication cost.²⁸²⁹

Here's the honest limitation before the value case.

Do not pay Ro expecting its insurance concierge to unlock TRICARE coverage. If using your TRICARE copay is your priority, your PCM or a TRICARE network clinic is the better path, full stop. We don't earn a cent on that referral, and it's what we'd tell our own family.

But a cash-pay prescription does not depend on getting a TRICARE payment approval first. Ro offers FDA-approved options including Wegovy, Zepbound, and Foundayo, with clinical care and pharmacy fulfillment arranged through its program. You still need to be eligible and receive a prescription.²⁹²⁸

Ro says cash-pay prescriptions sent to its own or partner pharmacies ship within a week once prescribed. That is a provider-stated shipping estimate—not a promise that a new visitor will receive medication this week.²⁸

What does Ro add to the medication price?

Get started for $39, then as low as $74/month with an annual plan paid upfront—or $149/month on the monthly plan. Medication is billed separately. The annual figure is a monthly equivalent, not a $74 monthly payment. Ro says it refunds the initial $39 if you are not eligible for GLP-1 treatment.²⁹

Here's the cost difference in plain numbers:

Our calculations use the published medication and membership prices checked September 22, 2026. They are not checkout quotes; your dose, offer eligibility, billing plan, and any additional charges must match the example.¹⁹²⁹

That's more than an approved TRICARE copay. The benefit is the care and fulfillment support—not a cheaper drug benefit or a guaranteed earlier approval.

Already have a prescriber? Check the manufacturer-direct prices below before adding a membership. Need help finding a prescriber and arranging treatment? That's the service a program like Ro adds.

Does that sound like your situation—you've decided to pay cash and want the care arranged in one place? Then see what Ro is quoting today.

See Ro's current self-pay prices and membership fees →

Sponsored provider link. Medication is extra. Ro's TRICARE option is cash-pay, subject to eligibility and clinical review.

What about Sesame Care?

Sesame's weight-loss program is another way to arrange care for a separate medication purchase. Its current month-to-month program is $99 per month, with medication extra. It advertises lower monthly equivalents on longer commitments, including $59 per month with an annual subscription. Compare the total commitment before paying; a program fee is not the drug price or a promise of a prescription.³⁰

Compare Sesame's program fee and medication costs →

Sponsored provider link. Confirm the exact service, clinician, eligibility, and total price before paying. Do not assume a Costco or commercial-insurance promotion applies to a TRICARE member.

What if TRICARE won't cover you? (TRICARE For Life, direct care, NATO)

TRICARE stopped covering weight-loss drugs for TRICARE For Life beneficiaries, direct-care-only beneficiaries, and NATO/Partnership-for-Peace members on August 31, 2025. If you're in one of those groups, TRICARE's own page says you pay 100% of the cost even with an approved prior authorization, and you can't fill weight-loss drugs at a military pharmacy.⁷

The change did not end diabetes-drug coverage for diabetes. That is a separate benefit with its own requirements.³¹

If that's you, we're sorry. The coverage change affected people who'd already been approved. The Military Officers Association of America described TFL beneficiaries as “frustrated about being left out of efforts to improve access to GLP-1s.” It also explained the next gap: the Medicare Bridge requires Part D, while most TFL members get their drug coverage through TRICARE instead.³²

Check these paths before paying for a membership. The one we feature commercially comes after the direct options, on purpose.

Sources: CMS Bridge information, NovoCare, LillyDirect, and provider pricing.^333419352029

Who can use the Medicare GLP-1 Bridge?

The Bridge runs from July 1, 2026, through December 31, 2027. It is separate from TRICARE and from the normal Part D benefit payment structure. Eligible medicines include Foundayo, Wegovy's listed formulations, and Zepbound KwikPen—not Zepbound's single-dose vial or single-dose pen.³⁴

CMS's clinical rules apply at the start of GLP-1 therapy. In addition to eligible Part D enrollment, age 18 or older, and ongoing lifestyle treatment, they include these alternatives:

For this program, uncontrolled high blood pressure means systolic pressure above 140 or diastolic pressure above 90 despite two blood-pressure medicines. These are CMS Bridge rules, not the TRICARE phentermine-exception rules.³⁶

The $50 payment does not count toward the Part D deductible or out-of-pocket limit. A GLP-1 prescribed for a use eligible for ordinary Part D coverage must follow that benefit instead; the Bridge is not a workaround for such a denial.³⁴³⁶

Check the official CMS eligibility information and our Medicare GLP-1 Bridge guide. To discuss enrollment, call 1-800-MEDICARE (1-800-633-4227) before changing coverage just for this program.³⁶

What are the manufacturer-direct cash prices?

Prices checked September 22, 2026. These are medication-only self-pay prices, not TRICARE copays. Injection offers below generally use a 28-day supply; tablet offers use 30 days. Dose changes must follow your prescriber's plan.

Sources: NovoCare's current pricing and terms, LillyDirect's product pages, and Lilly's self-pay terms. Supplies, clinician fees, and charges outside the stated offer can be additional.^1935262037

NovoCare Pharmacy is operated by CoAssist Pharmacy, doing business as NovoCare Pharmacy; it is not a clinic visit included in the drug price. Government-insured patients who meet the self-pay terms must keep the purchase outside insurance, without submitting it for reimbursement or counting it toward plan spending requirements.¹⁹

Have a prescriber already? Start with NovoCare's Wegovy prices, LillyDirect's Zepbound prices, or LillyDirect's Foundayo prices. These are direct manufacturer-program links, not our affiliate links.

Need a clinician as well as the medication? Compare the added care fee rather than paying for a membership you don't need.

Check Ro's TRICARE cash-pay eligibility information →

Sponsored provider link. This page explains eligibility; it is not an individual approval or a TRICARE coverage check.

What about a compounded product?

Compounded GLP-1s are not FDA-approved. They are not the same finished products as Wegovy or Zepbound. FDA says compounded drugs should be used only when a patient's medical need cannot be met by an FDA-approved drug.³⁸

TRICARE has rules for some compounded prescriptions, so “TRICARE never covers any compound” would be too broad. We did not verify a covered compounded semaglutide or tirzepatide weight-loss option.³⁹

If your clinician is considering compounding for a specific medical need, start with how to verify a compounding pharmacy's license. A pharmacy license does not turn a compounded drug into an FDA-approved product.

What if TRICARE says no?

A TRICARE denial is not one thing. Missing records, a step-therapy gap, a mismatch between the drug and its use, and a benefit exclusion need different responses. Read the written reason first. For an Express Scripts pharmacy appeal, TRICARE says the letter must be postmarked within 90 days of the decision.⁴⁰

Check these six points before you assume it's over. They are troubleshooting questions, not a claim that every denial can be reversed.

Call Express Scripts at 877-363-1303 and ask:

“I'm checking a decision for my exact drug and strength. Was this a benefit exclusion, an unmet clinical requirement, missing information, or a pharmacy-claim problem? Which form or records does my provider need, and what is my appeal deadline?”⁴¹⁴⁰

For USFHP, use your designated plan's contact and appeal instructions instead.²³

How did we compare the options and verify this page?

We compared treatment evidence, approved uses, benefit rules, and costs—not personal approval odds. The head-to-head trial supports one specific weight-loss comparison. It does not establish a universal best medication, a shared copay, or a faster insurance decision.

The original work here is the assembly: matching the drug comparison to coverage checks, putting cash prices on consistent supply units, calculating the medication-plus-membership examples, and turning the unresolved checks into a six-question appointment sheet. We did not conduct a clinical trial, enroll as a patient, or obtain an individual insurance approval.

Provider-stated vs. what we verified

Sources: the providers' and manufacturers' own pages. These are verified public statements, not independent tests of their service.^282930192620

What we actually verified

Checked September 22, 2026: TRICARE's current public coverage guidance and copays; military-pharmacy access; the distinction between USFHP and the standard pharmacy program; published DoD criteria; current drug labels and the cited trials; the Medicare Bridge rules; the listed self-pay prices; and provider-stated membership and eligibility terms.

Not independently verified: each drug's live formulary tier, every September 2026 medication-specific PA-form detail, your own eligibility, pharmacy stock, or a completed checkout. Use the official formulary result and your benefit administrator to settle those checks.

Still smart to spot-check: your exact product result, required forms, quantity limit, pharmacy stock, current offer terms, and the expiry date on any approval. Those are the fields on the appointment checklist—not loose ends you have to guess at.

About testimonials

You won't find “I got approved in two weeks!” quotes here. One person's approval does not establish yours. The quoted outside voice is MOAA's account of the coverage change—not a patient result, proof of medical benefit, or approval forecast.

What about teenagers, switching drugs, or other edge cases?

Age, the medical use, and an existing approval can change the next step. Bring the facts that apply to you, rather than trying to fit yourself into an example from someone else's form.

My teenager is 12 to 17. Which drug?

Wegovy injection and Saxenda both have FDA-approved adolescent weight-management uses, with different eligibility details. Saxenda's label includes a body-weight requirement above 60 kg. Do not use an adult BMI or renewal percentage as the teen rule; have the provider check the current drug-specific pediatric criteria.²⁹

I have sleep apnea but my BMI is 28.

Zepbound's FDA-approved sleep-apnea use is for adults with obesity. Its weight-management use is separate and includes some adults with overweight plus a weight-related condition. Ask your clinician which use is medically appropriate, then check the matching benefit requirements.⁸

I lost weight on phentermine and stalled.

Bring the dates, starting and ending weights, current BMI, and treatment notes. Ask how the current form handles a partial response and whether any other requirement applies. Do not assume that a question number quoted from an older or different plan's form guarantees approval.

I'm on Ozempic for diabetes and want Zepbound for weight.

Do not combine them on your own. Zepbound's labeling does not recommend use with another GLP-1 receptor agonist. A switch requires a prescriber-led treatment plan and a benefit review. Our Does TRICARE cover Mounjaro? page covers the diabetes side.⁸

Can I switch from Wegovy to Zepbound mid-approval?

An approval for one product is not proof that another is approved. Before switching, have the office confirm whether a new PA is needed, which records carry over, and which pharmacy can fill the new product. Do not rely on an unverified “filled within six months” rule.²³

I'm overseas.

Prime Overseas and Select Overseas are included among eligible plan families, but the prescription and claim process can differ. Confirm the required approval, fill location, and reimbursement instructions before paying.⁷²⁷

What safety information should I bring up before choosing?

Tell your clinician about pregnancy or plans for pregnancy; a personal or family history of medullary thyroid cancer or MEN2; severe stomach problems; past serious drug allergies; and every medicine you take. Wegovy and Zepbound carry important warnings and can cause digestive side effects. They are not weight-loss treatments to use during pregnancy.²⁸

For Zepbound, people using oral hormonal birth control should discuss a non-oral method or added barrier protection for four weeks after starting and after each dose increase, as its label directs.⁸

The lowest price or largest trial number is not the right choice when the medicine is wrong for your health.

Frequently asked questions

What is the best GLP-1 on the TRICARE formulary for weight loss?

Zepbound has the stronger result in the direct comparison with Wegovy up to 2.4 mg: 20.2% vs. 13.7% average weight loss at 72 weeks in adults with obesity without diabetes. The best option to discuss still depends on your medical needs, approved product, and cost. That trial did not compare Wegovy HD or the pill.¹

Does TRICARE cover Zepbound and Wegovy for weight loss in 2026?

Yes, for eligible beneficiaries who meet the coverage and approval requirements. Weight-loss drug coverage is not available to TRICARE For Life, direct-care-only, or NATO/Partnership-for-Peace beneficiaries under the stated exclusion.³⁷

Is Zepbound or Wegovy cheaper on TRICARE?

We did not verify a drug-specific winner on cost. $44 home delivery and $48 network retail are standard brand-formulary rates, not proof that every version of both drugs has that tier. Compare the exact product, pharmacy, and days supplied.⁴

Does TRICARE require step therapy for Zepbound or Wegovy?

The published adult weight-management criteria include a generic-drug trial or a supported exception. The separate published Zepbound sleep-apnea criteria do not list that trial. Your provider should confirm the requirements on the current form for your actual medical use.⁶

Does TRICARE cover the Wegovy pill or Foundayo?

A current product-level check is still needed. FDA approval does not settle TRICARE coverage, and omission from a short FAQ is not proof of noncoverage. Search the exact tablet and strength, or ask your pharmacy benefit administrator to check it.¹⁶

Does TRICARE cover Saxenda?

TRICARE names Saxenda as a weight-management option and lists prior-authorization and medical-necessity requirements. It is a daily injection. Its suitability and cost need to be checked rather than treating it as an automatic last-place option.³⁹

Does TRICARE For Life cover GLP-1s for weight loss?

No under the weight-loss exclusion effective August 31, 2025. Diabetes treatment remains a separate coverage question. The Medicare GLP-1 Bridge is also separate and requires eligible Part D enrollment and clinical approval.³¹³⁴

Can I use the $25 Wegovy or Zepbound savings card with TRICARE?

Not the commercial-insurance copay offer. Separate self-pay offers can permit eligible government-insured patients to buy outside insurance; read the terms for the exact offer, not just the advertised price.²⁵²⁶

How long does a TRICARE GLP-1 approval last?

The verified DoD policy document lists one-year approvals for the discussed Wegovy/Zepbound criteria. Your current approval letter controls your actual expiry date, and the current renewal form controls what the office must submit. Do not assume one adult or teen renewal threshold applies to every product and use.⁶

Can a telehealth doctor get TRICARE to cover my GLP-1?

Telehealth alone does not decide coverage. The clinician and visit must meet the applicable TRICARE requirements. Confirm network participation and billing before paying; a cash-pay program's willingness to treat you is not proof it can use your benefit. See GLP-1 providers that accept TRICARE.³²³

Still not sure which GLP-1 program is right for you? Start with your situation, not a provider ad.

Find My GLP-1 Path →

Your situation changes the answer. Use the tool to explore treatment paths. For the appointment itself, bring the six-question TRICARE checklist—and confirm the benefit before paying for a program.

Public sources and offer terms checked September 22, 2026. The dates of older research and policy documents are identified where their findings are used.

The RX Index provides independent guidance for choosing your GLP-1 path. This page is educational and is not medical advice. Confirm your current benefit, exact product, and prescription requirements before making treatment or spending decisions.

Related guides: TRICARE Wegovy Prior Authorization · Does TRICARE Cover Zepbound? · Does TRICARE Cover Wegovy? · Does TRICARE Cover Mounjaro? · GLP-1 Providers That Accept TRICARE · Medicare GLP-1 Bridge: How to Apply · Ro GLP-1 Cost

Sources

1. Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine, 2025. SURMOUNT-5.
2. Novo Nordisk. Wegovy Prescribing Information, current U.S. label, including clinical-study results and product-specific indications.
3. TRICARE. Does TRICARE cover Wegovy, Ozempic, and Mounjaro?, updated August 6, 2026.
4. TRICARE. Pharmacy Costs, including the calendar-year 2026–2027 schedule.
5. FDA. FDA Approves First Medication for Obstructive Sleep Apnea, December 20, 2024.
6. Department of Defense. February 2025 Pharmacy and Therapeutics Committee Minutes, including Appendix D. This is the dated policy document reviewed, not a verified September 2026 prescription form.
7. TRICARE. Weight Loss Products, updated August 5, 2026.
8. Eli Lilly. Zepbound Prescribing Information, current U.S. label.
9. Novo Nordisk. Saxenda Prescribing Information, current U.S. label.
10. Eli Lilly. Foundayo Prescribing Information, current U.S. label.
11. Wharton S, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP). Lancet Diabetes & Endocrinology, 2025.
12. Novo Nordisk. Higher dose of Wegovy provided average weight loss of 21% in people with obesity, June 20, 2025. Reports both treatment-policy and adherence-based estimates.
13. Novo Nordisk. Oral semaglutide 25 mg data at ObesityWeek 2025; see also the OASIS 4 results in current Wegovy prescribing information.
14. Pi-Sunyer X, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 2015.
15. Eli Lilly. Complete ATTAIN-1 results published in The New England Journal of Medicine, September 16, 2025.
16. TRICARE. Getting a New Prescription? Check TRICARE Formulary Search Tool. Open the official tool.
17. Novo Nordisk. FDA approves Novo Nordisk's Wegovy pill, December 22, 2025. Manufacturer announcement; current uses are checked against prescribing information.
18. FDA. FDA Approves First New Molecular Entity Under National Priority Voucher Program, April 1, 2026.
19. NovoCare. Wegovy self-pay pricing and terms.
20. Eli Lilly. Foundayo through LillyDirect, dose prices and Journey offer conditions.
21. TRICARE. Changes to Your TRICARE Prescription Drug Copayments in 2026.
22. TRICARE. What's the difference between prior authorization and medical necessity?.
23. TRICARE. Getting Prior Authorizations for TRICARE Prescriptions: Your Questions Answered.
24. Express Scripts. GLP-1 Medications: Diabetes and Weight Management.
25. NovoCare. Wegovy commercial savings-card eligibility and separate savings and self-pay terms.
26. Eli Lilly. Zepbound full terms and conditions, including separate commercial and self-pay offers.
27. TRICARE. Q&A: Understanding TRICARE coverage of weight loss medications overseas, including International SOS and Express Scripts submission instructions.
28. Ro. Weight Loss Program and Insurance.
29. Ro. Weight-loss pricing.
30. Sesame. Online Weight Loss Program.
31. Express Scripts, TRICARE Pharmacy Program. Changes to Your TRICARE Pharmacy Benefit.
32. Military Officers Association of America. New Medicare GLP-1 Program Excludes TRICARE For Life Beneficiaries, June 24, 2026.
33. CMS. Medicare GLP-1 Bridge.
34. CMS. Medicare GLP-1 Bridge: Information for Part D Plans.
35. Eli Lilly. Zepbound through LillyDirect.
36. CMS. Medicare GLP-1 Bridge: Information for Providers.
37. Eli Lilly. Foundayo full terms and conditions, including temporary prices through December 31, 2026, and the 45-day refill condition.
38. FDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
39. TRICARE. Compound Drugs.
40. TRICARE. Pharmacy Appeals.
41. Express Scripts, TRICARE Pharmacy Program. Contact Us.